CELUW
Celularity Inc
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Gross Profit
$6.8M
↑ 499.7%
Net Income
$-91716000
↓ 58.4%
Revenue
$26.6M
↓ 51.0%
Total Liabilities
$145.4M
↑ 17.4%
Operating Income
$-61308000
↓ 59.8%
Total Assets
$107.3M
↓ 19.1%
EPS (Diluted)
$-3.59
↓ 36.0%
Cash & Equivalents
$6.2M
↑ 736.7%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/30/2026 View on SEC
8-K 6/25/2026 View on SEC
4 6/23/2026 View on SEC
4 6/23/2026 View on SEC
4 6/23/2026 View on SEC
SCHEDULE 13D/A 6/23/2026 View on SEC
8-K 6/12/2026 View on SEC
8-K 6/3/2026 View on SEC
8-K 5/28/2026 View on SEC
NT 10-Q 5/15/2026 View on SEC

Company Information

Field Value
Ticker CELUW
Company Name Celularity Inc
CIK 1752828
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (908) 768-2170